Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. FiguresIn EMPA-REG OUTCOME, EMPA given in addition to standard of care significantly reduced the risk of cardiovascular (CV) (HR 0.62 [95% CI 0.49, 0.77]) and all-cause (0.68 [0.57, 0.82]) mortality vs placebo (PBO) in patients with type 2 diabetes (T2DM) and established CV disease.
3.3 Wat vind je van dit boek? Geef jouw beoordeling. 1 2 6 1 0 Willen dit boek lezen 9 Lezen dit boek 0 Hebben dit boek gelezen 12 De Nederlandse Boekenbon is supporter van lezerscommunity Hebban
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
